Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 3/20 | 0.43 |
| ▸ | HSD17B2 | P37059 | 3/20 | 0.43 |
| ▸ | ACHE | P22303 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1811899 | 1.00 | HSD17B1 (0.43) | HSD17B1HSD17B2ACHELMNATSHR | |
| SCHEMBL19817592 | 1.00 | HSD17B1 (0.43) | HSD17B1HSD17B2ACHELMNATSHR | |
| SCHEMBL12926846 | 1.00 | HSD17B1 (0.43) | HSD17B1HSD17B2ACHELMNATSHR | |
| SCHEMBL20201647 | 1.00 | HSD17B1 (0.43) | HSD17B1HSD17B2ACHELMNATSHR | |
| SCHEMBL14267126 | 1.00 | HSD17B1 (0.43) | HSD17B1HSD17B2ACHELMNATSHR | |
| SCHEMBL2774865 | 1.00 | HSD17B1 (0.43) | HSD17B1HSD17B2ACHELMNATSHR | |
| SCHEMBL12240207 | 1.00 | HSD17B1 (0.43) | HSD17B1HSD17B2ACHELMNATSHR | |
| SCHEMBL14877956 | 1.00 | HSD17B1 (0.43) | HSD17B1HSD17B2ACHELMNATSHR | |
| SCHEMBL19649023 | 1.00 | HSD17B1 (0.43) | HSD17B1HSD17B2ACHELMNATSHR | |
| SCHEMBL14047744 | 1.00 | HSD17B1 (0.43) | HSD17B1HSD17B2ACHELMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119730665-A | Preparation method of perovskite light transmission layer based on TPD small molecules and preparation method of perovskite battery device | 陕西师范大学 | 2025-03-28 | — | — | CN | disclosed |
| CN-118829263-A | Light emitting device, display screen, electronic equipment and preparation method of light emitting device | 北京小米移动软件有限公司 | 2024-10-22 | — | — | CN | disclosed |
| CN-118063519-A | Organic metal compound and organic electroluminescent device | 吉林奥来德光电材料股份有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-114805448-B | Iridium metal complex and organic electroluminescent device comprising iridium metal complex | 吉林奥来德光电材料股份有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-112812123-B | Hole compound, preparation method thereof and organic electroluminescent device | 吉林奥来德光电材料股份有限公司 | 2023-12-01 | — | — | CN | disclosed |
| EP-3481834-B1 | ORGANIC SEMICONDUCTING COMPOUNDS | RAYNERGY TEK INC (TW) | 2023-10-18 | — | — | EP | disclosed |
| CN-111825724-B | Phosphorescent iridium complex, preparation method thereof and electroluminescent device | 奥来德(长春)光电材料科技有限公司 | 2023-04-28 | — | — | CN | disclosed |
| US-20230131130-A1 | ORGANIC SEMICONDUCTING COMPOUND AND ORGANIC PHOTOELECTRIC COMPONENTS USING THE SAME | Raynergy Tek Incorporation (TW) | 2023-04-27 | — | — | US | disclosed |
| US-11637246-B2 | Organic semiconducting compounds | Raynergy Tek Incorporation (TW) | 2023-04-25 | — | — | US | disclosed |
| CN-111848687-B | Red light organic electroluminescent material, preparation method thereof and photoelectric device | 奥来德(长春)光电材料科技有限公司 | 2023-04-25 | — | — | CN | disclosed |
| US-7303824-B2 | Electroluminescent device | OLED-T LIMITED (GB) | 2007-12-04 | — | — | US | disclosed |
| US-20070254183-A1 | Electroluminescent materials and deivces | MERCK PATENT GMBH (DE) | 2007-11-01 | — | — | US | disclosed |
| US-20070252108-A1 | Electroluminescent Materials and Devices | MERCK PATENT GMBH (DE) | 2007-11-01 | — | — | US | disclosed |
| US-20070190357-A1 | Electroluminescent materials and devices | MERCK PATENT GMBH (DE) | 2007-08-16 | — | — | US | disclosed |
| EP-1578756-B1 | ELECTROLUMINESCENT MATERIALS AND DEVICES | OLED T LTD (GB) | 2007-06-13 | — | — | EP | disclosed |
| US-20070042219-A1 | Electroluminescent boron complexes | OLED-T LIMITED (GB) | 2007-02-22 | — | — | US | disclosed |
| US-7163772-B2 | Organic electrophotographic photo-receptor | ORIENT CHEMICAL INDUSTRIES, LTD. (JP) | 2007-01-16 | — | — | US | disclosed |
| US-7163772-B2 | Organic electrophotographic photo-receptor | ORIENT CHEMICAL INDUSTRIES, LTD. (JP) | 2007-01-16 | — | — | US | disclosed |
| US-20050154234-A1 | Triarylamine dimer derivative having amorphous phase | ORIENT CHEMICAL IND., LTD. (JP) | 2005-07-14 | — | — | US | disclosed |
| EP-1553079-A2 | Triarylamine dimer derivative having amorphous phase | Orient Chemical Industries, Ltd. (JP) | 2005-07-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070252108-A1 | Electroluminescent Materials and Devices | AAAS, ANXA1, ANXA2 | HSD17B1 4447/4885HSD17B2 4005/4885ACHE 439/4885 |
| US-20050154234-A1 | Triarylamine dimer derivative having amorphous phase | NAT1, AHR, ARNT | HSD17B1 1914/4885HSD17B2 1684/4885ACHE 4643/4885 |
| US-11637246-B2 | Organic semiconducting compounds | OCIAD2, OCIAD1, OSTC | HSD17B1 2569/4885HSD17B2 2404/4885ACHE 643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.